Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

NCT01776424 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27395

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention & Control

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Aspirin
DRUG: Aspirin placebo
DRUG: Rivaroxaban placebo
DRUG: Pantoprazole
DRUG: Pantoprazole placebo

Sponsor

Bayer

Collaborators

[object Object]
[object Object]